Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

JACC: Cardiovascular Interventions Publishes Peer Reviewed Article on Neovasc Reducer™ Patient Case

Canada NewsWire November 20, 2018

The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal

Benzinga.com  November 16, 2018

Neovasc Announces Third Quarter 2018 Financial Results

Canada NewsWire November 14, 2018

Neovasc Announces Third Quarter 2018 Financial Results Conference Call and Webcast

Canada NewsWire November 7, 2018

21 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  October 23, 2018

Neovasc Announces Successful Tiara™ "Live Case" at the 32nd Annual EACTS 2018 Meeting

Canada NewsWire October 22, 2018

Neovasc Announces Publication of a Peer-Reviewed Article on Tiara™ Cases in Circulation: Cardiovascular Interventions

Canada NewsWire October 16, 2018

Thinking about buying stock in Advanced Micro Devices, Amazon.com, Neovasc Inc., Sony Corporation or Square Incorporated?

PR Newswire October 11, 2018

10 Hottest Stocks From October 10, 2018

Benzinga.com  October 10, 2018

Mid-Day Market Update: Crude Oil Down Over 2%; Esterline Technologies Shares Spike Higher

Benzinga.com  October 10, 2018

Mid-Morning Market Update: Markets Open Lower; TransDigm To Buy Esterline

Benzinga.com  October 10, 2018

Neovasc Reducer™ Granted Breakthrough Device Designation from FDA

PR Newswire October 10, 2018

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule

Canada NewsWire October 9, 2018

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  October 3, 2018

Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer™

PR Newswire October 3, 2018

24 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  September 24, 2018

Neovasc's Tiara and Reducer to be Featured at TCT 2018 Conference

Canada NewsWire September 20, 2018

Neovasc Announces 100th Patient to Receive Reducer Therapy in Germany

PR Newswire September 19, 2018

Neovasc Announces Effective Date of Share Consolidation

PR Newswire September 18, 2018

The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares

Benzinga.com  September 18, 2018